Pertussis vaccination during pregnancy: Antibody persistence in infants (Q40717635)

23 September 2017

Pertussis vaccination during pregnancy: Antibody persistence in infants (English)

1 reference

23 September 2017

Alba Vilajeliu

1

1 reference

23 September 2017

Laia Ferrer

2

1 reference

23 September 2017

Jordina Munrós

3

1 reference

23 September 2017

Anna Goncé

4

1 reference

23 September 2017

Marta López

5

1 reference

23 September 2017

Josep Costa

6

1 reference

23 September 2017

José M Bayas

7

1 reference

23 September 2017

PERTU Working Group

8

1 reference

23 September 2017

language of work or name

English

0 references

publication date

2 June 2016

1 reference

23 September 2017

1 reference

23 September 2017

34

1 reference

23 September 2017

33

1 reference

23 September 2017

3719-3722

1 reference

Pertussis in the Era of New Strains of Bordetella pertussis

23 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.051

Combined tetanus-diphtheria and pertussis vaccine during pregnancy: transfer of maternal pertussis antibodies to the newborn

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.051

Importance of timing of maternal combined tetanus, diphtheria, and acellular pertussis (Tdap) immunization and protection of young infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.051

Safety and immunogenicity of tetanus diphtheria and acellular pertussis (Tdap) immunization during pregnancy in mothers and infants: a randomized clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.051

Sources of pertussis infection in young infants: a review of key evidence informing targeting of the cocoon strategy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.051

The protective role of maternally derived antibodies against Bordetella pertussis in young infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.051

A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales, 2012-2013.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.051

Correlation between pertussis toxin IgG antibodies in postvaccination sera and subsequent protection against pertussis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.051

The effect of timing of maternal tetanus, diphtheria, and acellular pertussis (Tdap) immunization during pregnancy on newborn pertussis antibody levels - a prospective study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.051

Pertussis vaccination during pregnancy in Belgium: Results of a prospective controlled cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.051

Maternal Immunization Earlier in Pregnancy Maximizes Antibody Transfer and Expected Infant Seropositivity Against Pertussis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.051

Safety of immunization during pregnancy: a review of the evidence of selected inactivated and live attenuated vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.05.051

10.1016/J.VACCINE.2016.05.051

7 January 2021

Identifiers

DOI

1 reference

23 September 2017

1 reference